Avoidance of concomitant medications known to decrease CYP2D6 activity might improve outcomes for patients with the wild-type genotype, but we are left with the question of what the best treatment ...
Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib Evidence has emerged that the clinical benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results